Blackrock Investment Management Llc decreased its stake in Hologic Inc (NASDAQ:HOLX) by 39.32% based on its latest Q4 2015 regulatory filing with the SEC. Blackrock Investment Management Llc sold 493,106 shares as the company’s stock declined 0.87% while stock markets rallied. The institutional investor held 760,855 shares of the health care company at the end of Q4, valued at $29.44 million, down from 1.25 million at the end of the previous reported quarter. Blackrock Investment Management Llc who had been investing in Hologic Inc since many months, could be less bullish the $9.85B market cap company. The stock increased 1.03% or $0.35 on March 24, hitting $34.35. About 1.68M shares traded hands. Hologic, Inc. (NASDAQ:HOLX) has declined 18.62% since August 19, 2015 and is downtrending. It has underperformed by 16.52% the S&P500.
Blackrock Investment Management Llc, which manages about $78.05 billion US Long portfolio, upped its stake in Nielsen Hldgs Plc () by 336,494 shares to 2.57 million shares, valued at $119.87M in Q4, according to the filing. It also increased its holding in Ishares Tr (DSI) by 169,538 shares in the quarter, for total 174,706 shares, and risen its stake in Ishares Tr (CSJ).
Blackrock Investment Management Llc is a New Jersey-based institutional investor with more than $211.00 billion AUM in November, 2014. This fund invests only a small percentage of its assets in equities and options. Blackrock Investment Management Llc is the 17th largest institutional investor in our database. Taken from Blackrock Investment Management latest Adv, the fund reported to have 1973 full and part-time employees. Among which 489 performing investment advisory and research functions. The institutional investor had more than 25800 clients.
The institutional sentiment increased to 1.28 in 2015 Q3. Its up 0.34, from 0.94 in 2015Q2. The ratio increased, as 31 funds sold all HOLX shares owned while 138 reduced positions. 66 funds bought stakes while 151 increased positions. They now own 281.67 million shares or 2.60% more from 274.53 million shares in 2015Q2.
Icahn Carl C holds 3.95% of its portfolio in HOLX for 28.15 million shares. Graybill Bartz & Assoc Ltd owns 106,905 shares or 3.43% of their US portfolio. Moreover, Decade Capital Management Llc has 2.94% invested in the company for 348,705 shares. The Texas-based Smith Asset Management Group Lp has invested 1.86% in the stock. South Texas Money Management Ltd, a Texas-based fund reported 722,237 shares.
Out of 16 analysts covering Hologic (NASDAQ:HOLX), 13 rate it “Buy”, 0 “Sell”, while 8 “Hold”. This means 62% are positive. Hologic was the topic in 12 analyst reports since July 24, 2015 according to StockzIntelligence Inc. Needham upgraded the stock on January 28 to “Buy” rating.
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. The company has a market cap of $9.85 billion. The Company’s business units are focused on diagnostics, breast health, GYN surgical and skeletal health. It has 53.76 P/E ratio. The Company’s diagnostics products include Aptima family of assays, its ThinPrep system, the Rapid Fetal Fibronectin Test and its Procleix blood screening assays.
Hologic, Inc. - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.